| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A booster shot to cure hemoglobinopathies
|
Walters, Mark C.
|
|
|
126 |
10 |
p. 1159-1161
|
article
|
| 2 |
AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia
|
Moradi Manesh, Donya
|
|
|
126 |
10 |
p. 1193-1202
|
article
|
| 3 |
Association between ENPP1 K173Q and stroke in a newborn cohort of 395 Brazilian children with sickle cell anemia
|
Belisário, André Rolim
|
|
|
126 |
10 |
p. 1259-1260
|
article
|
| 4 |
Autophagy is induced upon platelet activation and is essential for hemostasis and thrombosis
|
Ouseph, Madhu M.
|
|
|
126 |
10 |
p. 1224-1233
|
article
|
| 5 |
Biomarker of sensitivity to PR-104 in leukemia
|
Fulda, Simone
|
|
|
126 |
10 |
p. 1153-1154
|
article
|
| 6 |
Ceritinib in patients with advanced anaplastic lymphoma kinase–rearranged anaplastic large-cell lymphoma
|
Richly, Heike
|
|
|
126 |
10 |
p. 1257-1258
|
article
|
| 7 |
Chalandon Y, Thomas X, Hayette S, et al; Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL). Randomized study of reduced-intensity chemotherapy combined with imatinib in adults with Ph-positive acute lymphoblastic leukemia. Blood. 2015;125(24):3711-3719.
|
|
|
|
126 |
10 |
p. 1261
|
article
|
| 8 |
Correction of murine hemoglobinopathies by prenatal tolerance induction and postnatal nonmyeloablative allogeneic BM transplants
|
Peranteau, William H.
|
|
|
126 |
10 |
p. 1245-1254
|
article
|
| 9 |
Disease evolution and outcomes in familial AML with germline CEBPA mutations
|
Tawana, Kiran
|
|
|
126 |
10 |
p. 1214-1223
|
article
|
| 10 |
Editorial Board
|
|
|
|
126 |
10 |
p. i
|
article
|
| 11 |
Expanding the peptidome for immunotherapy
|
Neefjes, Jacques
|
|
|
126 |
10 |
p. 1154-1156
|
article
|
| 12 |
Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner
|
Mochizuki-Kashio, Makiko
|
|
|
126 |
10 |
p. 1172-1183
|
article
|
| 13 |
fVIII binds platelets + fibrin: no PS!
|
Pratt, Kathleen P.
|
|
|
126 |
10 |
p. 1158-1159
|
article
|
| 14 |
Getting a handle on hereditary CEBPA mutations
|
DiNardo, Courtney D.
|
|
|
126 |
10 |
p. 1156-1158
|
article
|
| 15 |
Inflammation rapidly reorganizes mouse bone marrow B cells and their environment in conjunction with early IgM responses
|
Moreau, Joshua M.
|
|
|
126 |
10 |
p. 1184-1192
|
article
|
| 16 |
Mantle cell lymphoma presenting as cardiac tamponade
|
Kumar, Abhijeet
|
|
|
126 |
10 |
p. 1255
|
article
|
| 17 |
mTOR: a new target in Erdheim-Chester disease?
|
Haroche, Julien
|
|
|
126 |
10 |
p. 1151-1152
|
article
|
| 18 |
Novel whole blood assay for phenotyping platelet reactivity in mice identifies ICAM-1 as a mediator of platelet-monocyte interaction
|
Armstrong, Paul C. J
|
|
|
126 |
10 |
p. e11-e18
|
article
|
| 19 |
Platelet binding sites for factor VIII in relation to fibrin and phosphatidylserine
|
Gilbert, Gary E.
|
|
|
126 |
10 |
p. 1237-1244
|
article
|
| 20 |
Rapid evolution of intracranial myeloid sarcoma in 4 weeks: images in blood
|
Prouet, Philippe
|
|
|
126 |
10 |
p. 1256
|
article
|
| 21 |
Sirolimus plus prednisone for Erdheim-Chester disease: an open-label trial
|
Gianfreda, Davide
|
|
|
126 |
10 |
p. 1163-1171
|
article
|
| 22 |
Suppression of in vitro megakaryopoiesis by maternal sera containing anti-HPA-1a antibodies
|
Liu, Zhi-Jian
|
|
|
126 |
10 |
p. 1234-1236
|
article
|
| 23 |
The antigenic landscape of multiple myeloma: mass spectrometry (re)defines targets for T-cell–based immunotherapy
|
Walz, Simon
|
|
|
126 |
10 |
p. 1203-1213
|
article
|
| 24 |
Victora GD, Dominguez-Sola D, Holmes AB, Deroubaix S, Dalla-Favera R, Nussenzweig MC. Identification of human germinal center light and dark zone cells and their relationship to human B-cell lymphomas. Blood. 2012;120(11):2240-2248.
|
|
|
|
126 |
10 |
p. 1262
|
article
|
Journal description